Doe Elom, Nguah Samuel B, Mensah Kofi B, Buabeng Kwame O
Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences Kwame Nkrumah University of Science and Technology Kumasi Ghana.
Department of Child Health, School of Medicine and Dentistry Kwame Nkrumah University of Science and Technology Kumasi Ghana.
Health Sci Rep. 2023 Oct 31;6(11):e1665. doi: 10.1002/hsr2.1665. eCollection 2023 Nov.
Pneumococcal infection prophylaxis (PIP) is necessary for children with sickle cell disease (SCD) due to the enhanced risk of pneumococcal infections and associated mortalities. PIP measures include periodic administration of pneumococcal conjugate vaccine (PCV), twice-daily administration of phenoxymethylpenicillin tablets, and nonpharmacological measures. This work assessed the attitude, knowledge, and perception of parents of SCD children on PIP, how parents obtain phenoxymethylpenicillin, and their preference for PIP.
This prospective cross-sectional study involved 200 parents of SCD children between 2 and 12 years old seeking medical care at the SCD clinic of the Komfo Anokye Teaching Hospital, Ghana. Infants involved had hemoglobin SS, SC, or S-βthal. A survey questionnaire (written) was administered to gather and interpret the data using Statistical Package for Social Sciences version 25 software.
Out of 200 respondents in this study, 12% knew vaccination could prevent pneumococcal disease, but only 4% had heard about PCV, 96% had heard about phenoxymethylpenicillin tablets, and 40% knew it could prevent it. Although phenoxymethylpenicillin is reimbursed on national insurance, 87% obtained the tablets from outside the hospital with cash, whereas 12% obtained the tablets from the hospital either on insurance or with cash. About 38% mentioned that they had discontinued treatment with tablets due to intentional withdrawal, lack of funds, noncompliant children, and running out of medicine. All but 2% of respondents said they would prefer vaccines to tablets.
There is a significant shortfall in knowledge, attitude, and perception of parents of SCD children concerning PIP, which warrants education and awareness creation on PIP in sickle cell clinics to ensure optimum clinical and health outcomes and reduce morbidity and mortality related to such infections.
由于镰状细胞病(SCD)患儿感染肺炎球菌的风险增加以及相关死亡率上升,因此有必要对其进行肺炎球菌感染预防(PIP)。PIP措施包括定期接种肺炎球菌结合疫苗(PCV)、每日两次服用苯氧甲基青霉素片以及非药物措施。本研究评估了SCD患儿家长对PIP的态度、知识和认知,家长获取苯氧甲基青霉素的方式以及他们对PIP的偏好。
这项前瞻性横断面研究纳入了200名2至12岁在加纳Komfo Anokye教学医院SCD诊所就医的SCD患儿的家长。纳入的婴儿患有血红蛋白SS、SC或S-β地中海贫血。使用社会科学统计软件包第25版软件发放一份调查问卷(书面形式)来收集和解读数据。
在本研究的200名受访者中,12%知道接种疫苗可预防肺炎球菌疾病,但只有4%听说过PCV,96%听说过苯氧甲基青霉素片,40%知道它可以预防疾病。尽管苯氧甲基青霉素可通过国家保险报销,但87%的家长是用现金从医院外获取该片剂,而12%的家长是通过保险或现金从医院获取该片剂。约38%的家长表示,由于主动停药、资金短缺、孩子不配合以及药物用完,他们已停止服用该片剂治疗。除2%的受访者外,所有受访者均表示他们更倾向于使用疫苗而非片剂。
SCD患儿家长在PIP方面的知识、态度和认知存在显著不足,这就需要在镰状细胞病诊所开展有关PIP的教育和宣传,以确保获得最佳的临床和健康结果,并降低与此类感染相关的发病率和死亡率。